FDA Approves New Treatment for Scleroderma
In early September 2019, the Food and Drug Administration (FDA) approved a new orphan drug for individuals who face a decline in their pulmonary function due to a…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.